| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Periodontal Diseases | 46 | 2022 | 450 | 8.740 |
Why?
|
| Guided Tissue Regeneration, Periodontal | 31 | 2022 | 148 | 6.740 |
Why?
|
| Bone Regeneration | 33 | 2020 | 433 | 6.520 |
Why?
|
| Periodontitis | 52 | 2023 | 558 | 6.200 |
Why?
|
| Dental Research | 15 | 2020 | 59 | 6.010 |
Why?
|
| Alveolar Bone Loss | 41 | 2023 | 390 | 5.670 |
Why?
|
| Tissue Engineering | 46 | 2022 | 1893 | 5.110 |
Why?
|
| Gingival Recession | 21 | 2023 | 201 | 4.900 |
Why?
|
| Dental Implants | 31 | 2023 | 762 | 4.820 |
Why?
|
| Gingiva | 23 | 2023 | 396 | 4.080 |
Why?
|
| Platelet-Derived Growth Factor | 28 | 2022 | 625 | 3.820 |
Why?
|
| Peri-Implantitis | 13 | 2023 | 94 | 3.680 |
Why?
|
| Periodontal Ligament | 18 | 2022 | 118 | 3.640 |
Why?
|
| Tissue Scaffolds | 17 | 2022 | 964 | 3.090 |
Why?
|
| Osseointegration | 12 | 2015 | 275 | 3.030 |
Why?
|
| Dental Implantation, Endosseous | 16 | 2018 | 509 | 3.030 |
Why?
|
| Mouth Diseases | 8 | 2020 | 242 | 2.860 |
Why?
|
| Periodontium | 18 | 2022 | 100 | 2.750 |
Why?
|
| Regeneration | 23 | 2020 | 1498 | 2.240 |
Why?
|
| Wound Healing | 37 | 2022 | 2798 | 2.230 |
Why?
|
| Tooth Loss | 9 | 2022 | 199 | 2.180 |
Why?
|
| Gingival Crevicular Fluid | 24 | 2022 | 93 | 2.170 |
Why?
|
| Proto-Oncogene Proteins c-sis | 19 | 2020 | 255 | 2.150 |
Why?
|
| Oral Health | 11 | 2023 | 477 | 2.080 |
Why?
|
| Regenerative Medicine | 12 | 2022 | 313 | 2.050 |
Why?
|
| Alveolar Ridge Augmentation | 7 | 2020 | 194 | 2.030 |
Why?
|
| Saliva | 16 | 2022 | 805 | 1.930 |
Why?
|
| Dentistry | 6 | 2020 | 117 | 1.820 |
Why?
|
| X-Ray Microtomography | 16 | 2023 | 434 | 1.780 |
Why?
|
| Periodontics | 6 | 2019 | 43 | 1.690 |
Why?
|
| Bone Morphogenetic Proteins | 13 | 2020 | 842 | 1.650 |
Why?
|
| Alveolar Process | 16 | 2020 | 294 | 1.640 |
Why?
|
| Chronic Periodontitis | 10 | 2020 | 101 | 1.560 |
Why?
|
| Dental Care | 5 | 2023 | 262 | 1.560 |
Why?
|
| Gingivitis | 14 | 2022 | 125 | 1.540 |
Why?
|
| Gene Transfer Techniques | 13 | 2018 | 1222 | 1.520 |
Why?
|
| Collagen | 26 | 2022 | 2689 | 1.490 |
Why?
|
| Oral Surgical Procedures | 4 | 2023 | 170 | 1.460 |
Why?
|
| Biocompatible Materials | 16 | 2022 | 1732 | 1.440 |
Why?
|
| Dental Plaque | 14 | 2016 | 208 | 1.390 |
Why?
|
| History of Dentistry | 2 | 2019 | 6 | 1.350 |
Why?
|
| Growth Substances | 14 | 2012 | 783 | 1.340 |
Why?
|
| Connective Tissue | 14 | 2023 | 424 | 1.290 |
Why?
|
| Dental Cementum | 11 | 2014 | 55 | 1.270 |
Why?
|
| Dental Materials | 3 | 2019 | 112 | 1.180 |
Why?
|
| Bone Morphogenetic Protein 7 | 11 | 2018 | 113 | 1.140 |
Why?
|
| Adenoviridae | 12 | 2018 | 1101 | 1.110 |
Why?
|
| Periodontal Attachment Loss | 23 | 2020 | 144 | 1.100 |
Why?
|
| Dental Implantation | 2 | 2018 | 51 | 1.070 |
Why?
|
| Dental Enamel Proteins | 4 | 2019 | 37 | 1.060 |
Why?
|
| Bone Transplantation | 7 | 2018 | 910 | 0.990 |
Why?
|
| Gingivoplasty | 5 | 2021 | 33 | 0.960 |
Why?
|
| Porphyromonas gingivalis | 9 | 2022 | 168 | 0.950 |
Why?
|
| Doxycycline | 8 | 2010 | 329 | 0.920 |
Why?
|
| Periodicals as Topic | 5 | 2019 | 1459 | 0.910 |
Why?
|
| Bacteroidaceae Infections | 2 | 2013 | 32 | 0.900 |
Why?
|
| Insurance, Dental | 2 | 2021 | 55 | 0.890 |
Why?
|
| Osteogenesis | 16 | 2016 | 1295 | 0.880 |
Why?
|
| Tooth | 6 | 2020 | 208 | 0.880 |
Why?
|
| Osteoprotegerin | 5 | 2015 | 176 | 0.880 |
Why?
|
| Tooth Extraction | 5 | 2020 | 225 | 0.830 |
Why?
|
| Polyesters | 6 | 2018 | 366 | 0.830 |
Why?
|
| Preventive Dentistry | 3 | 2020 | 21 | 0.810 |
Why?
|
| Dentists | 1 | 2023 | 173 | 0.790 |
Why?
|
| Genetic Markers | 3 | 2020 | 2633 | 0.790 |
Why?
|
| Leadership | 2 | 2022 | 1378 | 0.780 |
Why?
|
| Rats | 35 | 2023 | 24248 | 0.780 |
Why?
|
| Esthetics, Dental | 8 | 2023 | 259 | 0.770 |
Why?
|
| Schools, Dental | 1 | 2022 | 122 | 0.750 |
Why?
|
| Humans | 216 | 2023 | 752741 | 0.750 |
Why?
|
| Tooth Root | 9 | 2023 | 169 | 0.740 |
Why?
|
| Salivary Proteins and Peptides | 2 | 2011 | 52 | 0.720 |
Why?
|
| Stem Cell Transplantation | 6 | 2015 | 1626 | 0.720 |
Why?
|
| Recombinant Proteins | 22 | 2020 | 6624 | 0.720 |
Why?
|
| Microspheres | 5 | 2020 | 800 | 0.720 |
Why?
|
| Fibroblasts | 17 | 2016 | 4160 | 0.710 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 8 | 2016 | 1670 | 0.710 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2020 | 8285 | 0.700 |
Why?
|
| Transforming Growth Factor beta | 12 | 2016 | 2005 | 0.690 |
Why?
|
| Nod1 Signaling Adaptor Protein | 3 | 2015 | 14 | 0.690 |
Why?
|
| Biomimetic Materials | 3 | 2014 | 178 | 0.680 |
Why?
|
| Dental Caries | 4 | 2016 | 421 | 0.680 |
Why?
|
| Mouth | 3 | 2020 | 378 | 0.660 |
Why?
|
| Genetic Vectors | 8 | 2016 | 3417 | 0.640 |
Why?
|
| Multi-Institutional Systems | 1 | 2018 | 43 | 0.630 |
Why?
|
| Dental Prosthesis | 2 | 2014 | 15 | 0.630 |
Why?
|
| Biological Factors | 1 | 2019 | 166 | 0.620 |
Why?
|
| Aggressive Periodontitis | 2 | 2015 | 59 | 0.620 |
Why?
|
| Tooth Socket | 3 | 2020 | 125 | 0.620 |
Why?
|
| Absorbable Implants | 7 | 2015 | 346 | 0.620 |
Why?
|
| Dental Scaling | 10 | 2016 | 102 | 0.610 |
Why?
|
| Women | 1 | 2019 | 232 | 0.610 |
Why?
|
| Titanium | 3 | 2017 | 493 | 0.600 |
Why?
|
| Cementogenesis | 4 | 2004 | 10 | 0.600 |
Why?
|
| Surgical Flaps | 15 | 2020 | 1662 | 0.590 |
Why?
|
| Matrix Metalloproteinase 8 | 9 | 2022 | 56 | 0.580 |
Why?
|
| Respiratory Aspiration | 2 | 2014 | 82 | 0.560 |
Why?
|
| Antibodies, Immobilized | 1 | 2016 | 26 | 0.550 |
Why?
|
| Osteolysis | 1 | 2018 | 269 | 0.550 |
Why?
|
| Animals | 87 | 2023 | 169600 | 0.550 |
Why?
|
| Peptides | 17 | 2009 | 4430 | 0.550 |
Why?
|
| Biological Products | 3 | 2022 | 881 | 0.550 |
Why?
|
| Deglutition | 2 | 2014 | 204 | 0.540 |
Why?
|
| Periodontal Index | 14 | 2020 | 149 | 0.530 |
Why?
|
| Osteocalcin | 10 | 2015 | 273 | 0.530 |
Why?
|
| Collagen Type I | 16 | 2009 | 592 | 0.530 |
Why?
|
| Surface Properties | 11 | 2018 | 1182 | 0.520 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2015 | 87 | 0.520 |
Why?
|
| Technology, Dental | 1 | 2014 | 12 | 0.510 |
Why?
|
| Bone and Bones | 6 | 2018 | 2597 | 0.510 |
Why?
|
| Gingival Diseases | 2 | 2013 | 34 | 0.500 |
Why?
|
| Ligaments | 2 | 2017 | 129 | 0.490 |
Why?
|
| Maxillary Sinus | 2 | 2016 | 184 | 0.490 |
Why?
|
| Facial Bones | 3 | 2017 | 201 | 0.490 |
Why?
|
| Mesenchymal Stem Cells | 6 | 2022 | 1658 | 0.480 |
Why?
|
| Publishing | 7 | 2015 | 840 | 0.480 |
Why?
|
| Tooth Diseases | 2 | 2013 | 77 | 0.470 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 464 | 0.470 |
Why?
|
| Keratinocytes | 4 | 2015 | 792 | 0.470 |
Why?
|
| Root Planing | 6 | 2016 | 68 | 0.470 |
Why?
|
| Bone Resorption | 5 | 2014 | 721 | 0.460 |
Why?
|
| Bacteria | 8 | 2023 | 2145 | 0.450 |
Why?
|
| Interleukin-1 | 5 | 2015 | 1262 | 0.450 |
Why?
|
| Biofilms | 6 | 2015 | 622 | 0.450 |
Why?
|
| Foreign Bodies | 2 | 2014 | 405 | 0.450 |
Why?
|
| Finite Element Analysis | 2 | 2013 | 433 | 0.440 |
Why?
|
| Metals | 1 | 2017 | 727 | 0.440 |
Why?
|
| Polyglycolic Acid | 6 | 2010 | 408 | 0.440 |
Why?
|
| Periodontal Pocket | 14 | 2018 | 167 | 0.440 |
Why?
|
| Transduction, Genetic | 6 | 2009 | 905 | 0.430 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2015 | 575 | 0.430 |
Why?
|
| Biotechnology | 1 | 2014 | 280 | 0.430 |
Why?
|
| Furcation Defects | 3 | 2003 | 36 | 0.430 |
Why?
|
| Chemokine CXCL5 | 2 | 2010 | 28 | 0.420 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 2009 | 98 | 0.410 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2015 | 4041 | 0.410 |
Why?
|
| Chemokine CXCL2 | 2 | 2010 | 117 | 0.410 |
Why?
|
| Diagnosis, Oral | 1 | 2011 | 23 | 0.410 |
Why?
|
| Consensus | 8 | 2019 | 3023 | 0.400 |
Why?
|
| Craniofacial Abnormalities | 2 | 2012 | 316 | 0.400 |
Why?
|
| Epigenesis, Genetic | 4 | 2022 | 3686 | 0.390 |
Why?
|
| History, 21st Century | 4 | 2019 | 1552 | 0.390 |
Why?
|
| Arthritis, Experimental | 1 | 2013 | 291 | 0.390 |
Why?
|
| Polymers | 7 | 2018 | 1625 | 0.390 |
Why?
|
| Fibroblast Growth Factor 2 | 5 | 2016 | 599 | 0.380 |
Why?
|
| Immunization | 1 | 2015 | 1254 | 0.380 |
Why?
|
| Inflammation Mediators | 5 | 2014 | 1901 | 0.370 |
Why?
|
| Host-Pathogen Interactions | 5 | 2015 | 1483 | 0.370 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2012 | 2901 | 0.370 |
Why?
|
| Angiogenic Proteins | 1 | 2011 | 104 | 0.370 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2313 | 0.370 |
Why?
|
| Maxilla | 4 | 2022 | 476 | 0.360 |
Why?
|
| Insurance Coverage | 1 | 2021 | 1931 | 0.360 |
Why?
|
| Disease Models, Animal | 15 | 2020 | 18174 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 11 | 2013 | 7269 | 0.340 |
Why?
|
| Calcification, Physiologic | 5 | 2012 | 170 | 0.340 |
Why?
|
| History, 20th Century | 4 | 2019 | 2766 | 0.340 |
Why?
|
| Health Personnel | 1 | 2023 | 3246 | 0.340 |
Why?
|
| Molecular Mimicry | 1 | 2010 | 200 | 0.340 |
Why?
|
| Appointments and Schedules | 1 | 2013 | 429 | 0.340 |
Why?
|
| Bone Marrow Cells | 3 | 2013 | 2491 | 0.330 |
Why?
|
| Lactic Acid | 6 | 2010 | 1148 | 0.330 |
Why?
|
| Cell Differentiation | 11 | 2016 | 11553 | 0.330 |
Why?
|
| RANK Ligand | 2 | 2007 | 325 | 0.320 |
Why?
|
| Jaw | 4 | 2016 | 96 | 0.320 |
Why?
|
| Cells, Cultured | 13 | 2018 | 19270 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2022 | 3374 | 0.310 |
Why?
|
| Dogs | 9 | 2014 | 3915 | 0.310 |
Why?
|
| Alkaline Phosphatase | 7 | 2012 | 866 | 0.310 |
Why?
|
| Chemokine CXCL1 | 1 | 2008 | 100 | 0.310 |
Why?
|
| Male | 72 | 2022 | 354311 | 0.310 |
Why?
|
| Neovascularization, Physiologic | 3 | 2010 | 1355 | 0.310 |
Why?
|
| Interleukin-1beta | 7 | 2020 | 989 | 0.310 |
Why?
|
| Calcium Phosphates | 4 | 2016 | 171 | 0.300 |
Why?
|
| Drug Delivery Systems | 4 | 2012 | 2229 | 0.300 |
Why?
|
| Matrix Metalloproteinase 9 | 5 | 2023 | 641 | 0.290 |
Why?
|
| Radiography, Dental | 1 | 2007 | 53 | 0.290 |
Why?
|
| Microscopy, Electron, Scanning | 6 | 2017 | 964 | 0.290 |
Why?
|
| Gene Expression Regulation | 8 | 2014 | 12054 | 0.290 |
Why?
|
| Membranes, Artificial | 5 | 2014 | 377 | 0.280 |
Why?
|
| Rats, Nude | 3 | 2018 | 105 | 0.280 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 3 | 2022 | 70 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factor A | 8 | 2023 | 3512 | 0.280 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 596 | 0.270 |
Why?
|
| Cone-Beam Computed Tomography | 4 | 2019 | 459 | 0.270 |
Why?
|
| Mandible | 6 | 2015 | 744 | 0.270 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2011 | 512 | 0.270 |
Why?
|
| Nanostructures | 2 | 2008 | 548 | 0.260 |
Why?
|
| Antibodies | 2 | 2013 | 2454 | 0.260 |
Why?
|
| Dental Plaque Index | 6 | 2020 | 94 | 0.260 |
Why?
|
| Journal Impact Factor | 2 | 2019 | 158 | 0.260 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 3766 | 0.260 |
Why?
|
| Cytokines | 8 | 2023 | 7400 | 0.260 |
Why?
|
| Immunohistochemistry | 12 | 2014 | 11395 | 0.250 |
Why?
|
| Temporomandibular Joint Disorders | 2 | 2020 | 215 | 0.250 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2008 | 379 | 0.250 |
Why?
|
| Fibrinogen | 3 | 2022 | 893 | 0.240 |
Why?
|
| Evidence-Based Dentistry | 2 | 2014 | 14 | 0.240 |
Why?
|
| Follow-Up Studies | 17 | 2023 | 39223 | 0.240 |
Why?
|
| Treatment Outcome | 23 | 2023 | 64017 | 0.240 |
Why?
|
| Minocycline | 2 | 2002 | 163 | 0.240 |
Why?
|
| National Institute of Dental and Craniofacial Research (U.S.) | 2 | 2021 | 2 | 0.240 |
Why?
|
| Health Policy | 1 | 2016 | 2687 | 0.240 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2012 | 855 | 0.240 |
Why?
|
| Artifacts | 1 | 2013 | 1905 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2014 | 20346 | 0.230 |
Why?
|
| Bone Morphogenetic Protein 2 | 3 | 2016 | 353 | 0.230 |
Why?
|
| Analysis of Variance | 12 | 2012 | 6352 | 0.230 |
Why?
|
| Stem Cells | 3 | 2014 | 3581 | 0.230 |
Why?
|
| Antibodies, Monoclonal | 2 | 2020 | 9300 | 0.230 |
Why?
|
| Integrin-Binding Sialoprotein | 4 | 2012 | 23 | 0.230 |
Why?
|
| Medicare | 1 | 2021 | 6670 | 0.220 |
Why?
|
| Bone Remodeling | 1 | 2007 | 578 | 0.220 |
Why?
|
| Disease Progression | 11 | 2017 | 13364 | 0.220 |
Why?
|
| Biomedical Research | 2 | 2015 | 3349 | 0.220 |
Why?
|
| Adult | 47 | 2022 | 216658 | 0.220 |
Why?
|
| Statistics, Nonparametric | 9 | 2011 | 2888 | 0.210 |
Why?
|
| Palate | 1 | 2022 | 126 | 0.210 |
Why?
|
| Minerals | 1 | 2004 | 279 | 0.210 |
Why?
|
| Interleukin-8 | 4 | 2022 | 695 | 0.210 |
Why?
|
| Mice, Inbred DBA | 2 | 2013 | 642 | 0.210 |
Why?
|
| Blood Vessels | 1 | 2008 | 1127 | 0.210 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 1997 | 2002 | 0.200 |
Why?
|
| Lab-On-A-Chip Devices | 3 | 2012 | 434 | 0.200 |
Why?
|
| Female | 57 | 2022 | 385090 | 0.200 |
Why?
|
| Macrophages | 5 | 2021 | 5710 | 0.200 |
Why?
|
| Faculty, Dental | 1 | 2022 | 60 | 0.200 |
Why?
|
| Osteoarthritis | 3 | 2020 | 1049 | 0.200 |
Why?
|
| Middle Aged | 44 | 2017 | 216054 | 0.200 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2015 | 281 | 0.200 |
Why?
|
| Jaw, Edentulous, Partially | 2 | 2018 | 85 | 0.190 |
Why?
|
| Diabetes Complications | 2 | 2022 | 1356 | 0.190 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2014 | 310 | 0.190 |
Why?
|
| Bone Substitutes | 3 | 2016 | 230 | 0.190 |
Why?
|
| Immunoglobulin G | 3 | 2009 | 4575 | 0.190 |
Why?
|
| Bone Density | 7 | 2014 | 3504 | 0.190 |
Why?
|
| Klebsiella | 1 | 2020 | 47 | 0.190 |
Why?
|
| Cell Adhesion Molecules | 4 | 2012 | 1614 | 0.190 |
Why?
|
| Enterobacter | 1 | 2020 | 46 | 0.190 |
Why?
|
| Flow Cytometry | 5 | 2012 | 5974 | 0.180 |
Why?
|
| Forecasting | 5 | 2017 | 2956 | 0.180 |
Why?
|
| Mice | 22 | 2020 | 81766 | 0.180 |
Why?
|
| Cell Division | 7 | 2003 | 4549 | 0.180 |
Why?
|
| Bioengineering | 2 | 2018 | 98 | 0.170 |
Why?
|
| Osteoclasts | 4 | 2023 | 725 | 0.170 |
Why?
|
| Diffusion of Innovation | 2 | 2018 | 726 | 0.170 |
Why?
|
| Mouth Mucosa | 3 | 2017 | 435 | 0.170 |
Why?
|
| Extracellular Matrix | 5 | 2019 | 1747 | 0.170 |
Why?
|
| Stress, Mechanical | 4 | 2014 | 1687 | 0.170 |
Why?
|
| Longitudinal Studies | 10 | 2020 | 14219 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 10057 | 0.170 |
Why?
|
| Chlorhexidine | 1 | 2020 | 163 | 0.170 |
Why?
|
| Proteins | 3 | 2004 | 6093 | 0.170 |
Why?
|
| Materials Testing | 3 | 2017 | 869 | 0.170 |
Why?
|
| Microfluidics | 3 | 2011 | 665 | 0.170 |
Why?
|
| Surgical Wound Dehiscence | 2 | 2015 | 216 | 0.170 |
Why?
|
| Plastics | 1 | 2019 | 125 | 0.170 |
Why?
|
| Metalloendopeptidases | 2 | 1998 | 404 | 0.170 |
Why?
|
| Mouth, Edentulous | 2 | 2016 | 78 | 0.160 |
Why?
|
| Industry | 1 | 2021 | 365 | 0.160 |
Why?
|
| Cell Count | 3 | 2017 | 1856 | 0.160 |
Why?
|
| Diabetic Neuropathies | 1 | 2022 | 399 | 0.160 |
Why?
|
| Bone Density Conservation Agents | 4 | 2011 | 778 | 0.160 |
Why?
|
| Glycosaminoglycans | 3 | 2003 | 628 | 0.160 |
Why?
|
| Jaw Diseases | 2 | 2010 | 91 | 0.160 |
Why?
|
| Dental Restoration, Permanent | 1 | 2019 | 131 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 4733 | 0.150 |
Why?
|
| Cattle | 6 | 2017 | 3926 | 0.150 |
Why?
|
| Sialoglycoproteins | 4 | 2004 | 318 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 3766 | 0.150 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2010 | 647 | 0.150 |
Why?
|
| Aged | 31 | 2021 | 165629 | 0.150 |
Why?
|
| Rats, Inbred F344 | 1 | 2018 | 862 | 0.150 |
Why?
|
| Acid Phosphatase | 2 | 2007 | 141 | 0.150 |
Why?
|
| Exosomes | 1 | 2022 | 421 | 0.150 |
Why?
|
| Dental Restoration Failure | 1 | 2017 | 153 | 0.140 |
Why?
|
| United States | 8 | 2022 | 70772 | 0.140 |
Why?
|
| Pilot Projects | 11 | 2021 | 8413 | 0.140 |
Why?
|
| Blotting, Northern | 4 | 2003 | 1572 | 0.140 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 3500 | 0.140 |
Why?
|
| Particle Size | 2 | 2018 | 1648 | 0.140 |
Why?
|
| Radiography | 8 | 2020 | 7047 | 0.140 |
Why?
|
| Signal Transduction | 5 | 2013 | 23512 | 0.140 |
Why?
|
| Fusobacterium nucleatum | 5 | 2021 | 163 | 0.140 |
Why?
|
| Linear Models | 4 | 2017 | 5965 | 0.140 |
Why?
|
| Double-Blind Method | 9 | 2016 | 12202 | 0.140 |
Why?
|
| Carbohydrates | 1 | 2018 | 398 | 0.140 |
Why?
|
| Universities | 2 | 2021 | 970 | 0.140 |
Why?
|
| Smoking | 7 | 2013 | 9030 | 0.140 |
Why?
|
| Osteotomy | 2 | 2013 | 828 | 0.140 |
Why?
|
| Skull | 2 | 2014 | 830 | 0.140 |
Why?
|
| Campylobacter rectus | 1 | 2015 | 5 | 0.140 |
Why?
|
| Porphyromonas | 1 | 2015 | 6 | 0.140 |
Why?
|
| Porphyromonas endodontalis | 1 | 2015 | 9 | 0.140 |
Why?
|
| Meta-Analysis as Topic | 2 | 2018 | 1364 | 0.140 |
Why?
|
| Macaca fascicularis | 2 | 1996 | 916 | 0.140 |
Why?
|
| Organizational Objectives | 1 | 2018 | 438 | 0.130 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2009 | 431 | 0.130 |
Why?
|
| Radiography, Bitewing | 2 | 2015 | 36 | 0.130 |
Why?
|
| Culture Media, Serum-Free | 2 | 2008 | 157 | 0.130 |
Why?
|
| Endonucleases | 1 | 2018 | 379 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 691 | 0.130 |
Why?
|
| Mice, SCID | 5 | 2007 | 2693 | 0.130 |
Why?
|
| Implants, Experimental | 3 | 2008 | 104 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2022 | 4420 | 0.130 |
Why?
|
| Interleukins | 2 | 2010 | 794 | 0.130 |
Why?
|
| Immunogenetic Phenomena | 1 | 2014 | 23 | 0.130 |
Why?
|
| Down-Regulation | 4 | 2012 | 2987 | 0.130 |
Why?
|
| Tetrazolium Salts | 1 | 2014 | 95 | 0.130 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2014 | 36 | 0.130 |
Why?
|
| Azithromycin | 2 | 2007 | 196 | 0.130 |
Why?
|
| Integrin alpha2 | 1 | 2014 | 41 | 0.130 |
Why?
|
| Temporomandibular Joint | 2 | 2014 | 196 | 0.120 |
Why?
|
| Biomedical Engineering | 1 | 1996 | 294 | 0.120 |
Why?
|
| Dentistry, Operative | 1 | 2014 | 38 | 0.120 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 10256 | 0.120 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2014 | 95 | 0.120 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 9431 | 0.120 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2332 | 0.120 |
Why?
|
| Dietary Sucrose | 1 | 2016 | 245 | 0.120 |
Why?
|
| Delayed-Action Preparations | 2 | 2010 | 983 | 0.120 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 457 | 0.120 |
Why?
|
| Taxes | 1 | 2016 | 217 | 0.120 |
Why?
|
| Tetracyclines | 2 | 2008 | 60 | 0.120 |
Why?
|
| Mucous Membrane | 1 | 2018 | 673 | 0.120 |
Why?
|
| Epithelial Cells | 4 | 2017 | 3757 | 0.120 |
Why?
|
| Single-Blind Method | 4 | 2020 | 1593 | 0.120 |
Why?
|
| Dental Prophylaxis | 1 | 2013 | 29 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 17635 | 0.120 |
Why?
|
| Docosahexaenoic Acids | 1 | 2020 | 888 | 0.110 |
Why?
|
| Gingival Hemorrhage | 4 | 2013 | 49 | 0.110 |
Why?
|
| Prospective Studies | 11 | 2022 | 53863 | 0.110 |
Why?
|
| Point-of-Care Systems | 2 | 2012 | 1184 | 0.110 |
Why?
|
| Cell Line | 9 | 2017 | 16004 | 0.110 |
Why?
|
| Dental Enamel | 1 | 2013 | 63 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2017 | 6037 | 0.110 |
Why?
|
| Cohort Studies | 7 | 2021 | 40939 | 0.110 |
Why?
|
| Safety | 5 | 2016 | 1179 | 0.110 |
Why?
|
| Stomatitis | 1 | 2016 | 271 | 0.110 |
Why?
|
| Amino Acids | 1 | 1999 | 1744 | 0.110 |
Why?
|
| Dental Prosthesis Retention | 1 | 2012 | 34 | 0.110 |
Why?
|
| Organ Size | 2 | 2015 | 2265 | 0.110 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2012 | 55 | 0.110 |
Why?
|
| Procollagen | 4 | 2007 | 186 | 0.110 |
Why?
|
| Antibodies, Bacterial | 2 | 2009 | 1475 | 0.110 |
Why?
|
| Transfection | 1 | 2001 | 5882 | 0.110 |
Why?
|
| Diphosphonates | 2 | 2008 | 628 | 0.110 |
Why?
|
| Apatites | 1 | 2012 | 19 | 0.110 |
Why?
|
| HMGB1 Protein | 1 | 2014 | 136 | 0.110 |
Why?
|
| Dental Amalgam | 1 | 1992 | 67 | 0.110 |
Why?
|
| Michigan | 1 | 2013 | 350 | 0.110 |
Why?
|
| Treponema denticola | 2 | 2009 | 13 | 0.110 |
Why?
|
| Time Factors | 7 | 2015 | 40195 | 0.100 |
Why?
|
| Protein Array Analysis | 2 | 2011 | 412 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2007 | 1722 | 0.100 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 338 | 0.100 |
Why?
|
| Synovial Fluid | 1 | 2014 | 403 | 0.100 |
Why?
|
| Osteoblasts | 4 | 2001 | 1163 | 0.100 |
Why?
|
| Congresses as Topic | 2 | 2014 | 767 | 0.100 |
Why?
|
| Interleukin-10 | 2 | 2020 | 1205 | 0.100 |
Why?
|
| Bacterial Typing Techniques | 2 | 2011 | 256 | 0.100 |
Why?
|
| DNA Methylation | 2 | 2017 | 4315 | 0.100 |
Why?
|
| Training Support | 1 | 2012 | 113 | 0.100 |
Why?
|
| Teriparatide | 2 | 2011 | 225 | 0.100 |
Why?
|
| DNA, Bacterial | 4 | 2011 | 1467 | 0.100 |
Why?
|
| Colitis | 1 | 2020 | 1196 | 0.100 |
Why?
|
| Epigenomics | 1 | 2017 | 905 | 0.100 |
Why?
|
| Bicuspid | 1 | 2011 | 74 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2017 | 2499 | 0.100 |
Why?
|
| Transformation, Genetic | 1 | 2012 | 193 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2012 | 4194 | 0.100 |
Why?
|
| Histocompatibility | 1 | 2013 | 323 | 0.100 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2011 | 1371 | 0.100 |
Why?
|
| Mice, Inbred Strains | 2 | 2012 | 1830 | 0.100 |
Why?
|
| Bone Matrix | 1 | 2012 | 118 | 0.100 |
Why?
|
| Clinical Chemistry Tests | 1 | 2011 | 61 | 0.100 |
Why?
|
| Cell Cycle | 3 | 2010 | 2967 | 0.100 |
Why?
|
| Prosthesis Design | 2 | 2015 | 2127 | 0.100 |
Why?
|
| Angiostatins | 1 | 2011 | 67 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 581 | 0.100 |
Why?
|
| Gene Expression | 2 | 2001 | 7771 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2016 | 10252 | 0.100 |
Why?
|
| Beverages | 1 | 2016 | 818 | 0.100 |
Why?
|
| Aromatase Inhibitors | 1 | 2015 | 511 | 0.090 |
Why?
|
| Osteopontin | 2 | 2004 | 301 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2002 | 2376 | 0.090 |
Why?
|
| Clinical Trials as Topic | 4 | 2014 | 7970 | 0.090 |
Why?
|
| Microdissection | 1 | 2010 | 152 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 148 | 0.090 |
Why?
|
| Prevotella intermedia | 2 | 2021 | 16 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2010 | 162 | 0.090 |
Why?
|
| Chronic Disease | 7 | 2013 | 9223 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2013 | 3885 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2015 | 3487 | 0.090 |
Why?
|
| Demography | 1 | 2015 | 1661 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 6169 | 0.090 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2011 | 150 | 0.090 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2010 | 164 | 0.090 |
Why?
|
| Peptide Fragments | 6 | 2007 | 5124 | 0.090 |
Why?
|
| Nanofibers | 1 | 2010 | 68 | 0.090 |
Why?
|
| Patient Care Planning | 1 | 2016 | 921 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2016 | 250 | 0.090 |
Why?
|
| Interleukin-6 | 4 | 2014 | 3198 | 0.090 |
Why?
|
| Editorial Policies | 1 | 2015 | 458 | 0.090 |
Why?
|
| Young Adult | 7 | 2022 | 57267 | 0.090 |
Why?
|
| Luminescent Proteins | 2 | 2004 | 850 | 0.090 |
Why?
|
| Transgenes | 2 | 2005 | 1012 | 0.090 |
Why?
|
| Chemokine CXCL10 | 1 | 2011 | 318 | 0.090 |
Why?
|
| Registries | 3 | 2015 | 8216 | 0.090 |
Why?
|
| DNA | 5 | 2008 | 7312 | 0.080 |
Why?
|
| Case-Control Studies | 7 | 2022 | 21904 | 0.080 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2008 | 190 | 0.080 |
Why?
|
| DNA Repair | 1 | 2018 | 2058 | 0.080 |
Why?
|
| Bite Force | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 15433 | 0.080 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2009 | 90 | 0.080 |
Why?
|
| Administration, Topical | 4 | 2008 | 691 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2021 | 2321 | 0.080 |
Why?
|
| Interleukin-4 | 1 | 2012 | 1155 | 0.080 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 2010 | 119 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2010 | 262 | 0.080 |
Why?
|
| Disease Susceptibility | 2 | 2013 | 1779 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 2015 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 2702 | 0.080 |
Why?
|
| Subtraction Technique | 1 | 2011 | 521 | 0.080 |
Why?
|
| Quality of Life | 2 | 2022 | 13044 | 0.080 |
Why?
|
| Research Design | 2 | 2015 | 6118 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 444 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2020 | 14596 | 0.080 |
Why?
|
| Interprofessional Relations | 1 | 2014 | 1019 | 0.080 |
Why?
|
| Research Support as Topic | 1 | 2012 | 706 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4716 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2008 | 2287 | 0.080 |
Why?
|
| DNA Damage | 1 | 2017 | 2442 | 0.080 |
Why?
|
| Dental Sac | 2 | 2004 | 6 | 0.070 |
Why?
|
| Cathepsins | 1 | 2008 | 240 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2003 | 1731 | 0.070 |
Why?
|
| Pharmacogenetics | 1 | 2011 | 674 | 0.070 |
Why?
|
| Phosphotransferases | 1 | 2008 | 309 | 0.070 |
Why?
|
| Thiazoles | 1 | 2014 | 1484 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 901 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2013 | 23554 | 0.070 |
Why?
|
| Adenoviruses, Human | 1 | 2009 | 258 | 0.070 |
Why?
|
| Electrophoresis | 1 | 2007 | 240 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 2080 | 0.070 |
Why?
|
| Primates | 1 | 2009 | 547 | 0.070 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2012 | 987 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2014 | 10508 | 0.070 |
Why?
|
| Chemistry, Clinical | 1 | 2007 | 64 | 0.070 |
Why?
|
| Serum | 1 | 2008 | 213 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 2492 | 0.070 |
Why?
|
| Mice, Transgenic | 4 | 2008 | 9743 | 0.070 |
Why?
|
| Risk Factors | 7 | 2022 | 73094 | 0.070 |
Why?
|
| Collagenases | 2 | 1997 | 227 | 0.070 |
Why?
|
| Cluster Analysis | 2 | 2011 | 2719 | 0.070 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 1517 | 0.070 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 232 | 0.070 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2012 | 1124 | 0.070 |
Why?
|
| Nanotubes | 1 | 2007 | 76 | 0.070 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 394 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2016 | 2945 | 0.070 |
Why?
|
| Spleen | 1 | 2012 | 2369 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2012 | 5149 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3218 | 0.070 |
Why?
|
| Connective Tissue Cells | 1 | 2005 | 55 | 0.070 |
Why?
|
| Multipotent Stem Cells | 1 | 2007 | 203 | 0.070 |
Why?
|
| Inflammation | 3 | 2023 | 10751 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2022 | 3767 | 0.070 |
Why?
|
| Monocytes | 1 | 2015 | 2602 | 0.070 |
Why?
|
| Postmenopause | 1 | 2015 | 2478 | 0.070 |
Why?
|
| Primary Prevention | 1 | 2013 | 1182 | 0.070 |
Why?
|
| Porosity | 3 | 2014 | 360 | 0.070 |
Why?
|
| Interferon-gamma | 2 | 2017 | 3220 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2008 | 646 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2012 | 1553 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2009 | 3860 | 0.060 |
Why?
|
| Matched-Pair Analysis | 2 | 2003 | 287 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1653 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2014 | 11909 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2008 | 8414 | 0.060 |
Why?
|
| Histones | 1 | 2015 | 2615 | 0.060 |
Why?
|
| Health | 1 | 2008 | 394 | 0.060 |
Why?
|
| Tissue Transplantation | 1 | 2005 | 130 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2016 | 5144 | 0.060 |
Why?
|
| Pharmaceutical Vehicles | 3 | 2001 | 59 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1127 | 0.060 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 1295 | 0.060 |
Why?
|
| Amelogenin | 1 | 2003 | 15 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2011 | 8971 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2013 | 3941 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 1362 | 0.060 |
Why?
|
| Th17 Cells | 2 | 2021 | 771 | 0.060 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2016 | 140 | 0.060 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2006 | 162 | 0.060 |
Why?
|
| Patient Participation | 1 | 2013 | 1464 | 0.060 |
Why?
|
| Dependovirus | 1 | 2008 | 702 | 0.060 |
Why?
|
| Immunoglobulin A | 2 | 2022 | 996 | 0.060 |
Why?
|
| Giant Cells | 1 | 2004 | 188 | 0.060 |
Why?
|
| Simian virus 40 | 1 | 2004 | 297 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 738 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1210 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2015 | 2495 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2010 | 1543 | 0.060 |
Why?
|
| Immunoassay | 1 | 2007 | 749 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2007 | 721 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2004 | 284 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2004 | 462 | 0.060 |
Why?
|
| Biopsy | 2 | 2013 | 6771 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 2123 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 3837 | 0.050 |
Why?
|
| Kinetics | 3 | 2007 | 6482 | 0.050 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2003 | 135 | 0.050 |
Why?
|
| Cell Movement | 3 | 2008 | 5222 | 0.050 |
Why?
|
| Drug Synergism | 2 | 1997 | 1768 | 0.050 |
Why?
|
| Capnocytophaga | 2 | 1999 | 26 | 0.050 |
Why?
|
| Bacterial Load | 1 | 2023 | 154 | 0.050 |
Why?
|
| Vitamins | 1 | 2011 | 1636 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 894 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8607 | 0.050 |
Why?
|
| Adipose Tissue | 2 | 2012 | 3308 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2005 | 766 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2010 | 1107 | 0.050 |
Why?
|
| Luciferases | 1 | 2004 | 732 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 14761 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3814 | 0.050 |
Why?
|
| Dental Prosthesis Design | 1 | 2003 | 263 | 0.050 |
Why?
|
| Tooth Eruption | 2 | 2013 | 30 | 0.050 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 1367 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2004 | 874 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2012 | 2766 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 766 | 0.050 |
Why?
|
| Colony Count, Microbial | 3 | 2008 | 333 | 0.050 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2002 | 90 | 0.050 |
Why?
|
| Random Allocation | 3 | 2003 | 2426 | 0.050 |
Why?
|
| Lipopolysaccharides | 3 | 2015 | 2223 | 0.050 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 58361 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 2039 | 0.050 |
Why?
|
| Odontogenesis | 1 | 2000 | 66 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 3494 | 0.050 |
Why?
|
| Thiadiazines | 1 | 2020 | 10 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 690 | 0.050 |
Why?
|
| Clone Cells | 1 | 2004 | 1692 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 1522 | 0.040 |
Why?
|
| Communication | 1 | 2014 | 3815 | 0.040 |
Why?
|
| Phosphotyrosine | 2 | 1997 | 457 | 0.040 |
Why?
|
| Drug Combinations | 2 | 1996 | 1994 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 703 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2005 | 1998 | 0.040 |
Why?
|
| Genes, myc | 1 | 2001 | 401 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2022 | 78758 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2004 | 5006 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2013 | 3217 | 0.040 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 25454 | 0.040 |
Why?
|
| Lymphokines | 1 | 2003 | 945 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2022 | 367 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2003 | 834 | 0.040 |
Why?
|
| Placebos | 1 | 2004 | 1675 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2927 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3901 | 0.040 |
Why?
|
| Phenotype | 3 | 2022 | 16484 | 0.040 |
Why?
|
| Jaw, Edentulous | 2 | 2014 | 97 | 0.040 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1999 | 261 | 0.040 |
Why?
|
| Proteome | 1 | 2009 | 1809 | 0.040 |
Why?
|
| Nomograms | 1 | 2020 | 230 | 0.040 |
Why?
|
| Lasers | 1 | 2023 | 961 | 0.040 |
Why?
|
| Genotype | 1 | 2013 | 12970 | 0.040 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2005 | 829 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 1998 | 229 | 0.040 |
Why?
|
| Adsorption | 1 | 2018 | 202 | 0.040 |
Why?
|
| ROC Curve | 2 | 2020 | 3558 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 3761 | 0.040 |
Why?
|
| Streptococcus | 1 | 1998 | 197 | 0.040 |
Why?
|
| Health Promotion | 1 | 2010 | 2210 | 0.040 |
Why?
|
| Internet | 1 | 2010 | 3074 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2010 | 3586 | 0.040 |
Why?
|
| Static Electricity | 1 | 2018 | 266 | 0.040 |
Why?
|
| Ankylosis | 1 | 1998 | 39 | 0.040 |
Why?
|
| Specialties, Dental | 1 | 2017 | 35 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5799 | 0.040 |
Why?
|
| Fluoresceins | 1 | 1998 | 235 | 0.040 |
Why?
|
| Wallerian Degeneration | 1 | 1997 | 70 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7355 | 0.040 |
Why?
|
| Vitamin D | 1 | 2011 | 3259 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1997 | 180 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 1784 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 4298 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1544 | 0.040 |
Why?
|
| Combined Modality Therapy | 4 | 2014 | 8660 | 0.040 |
Why?
|
| Periodontal Debridement | 1 | 2016 | 8 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2017 | 428 | 0.040 |
Why?
|
| Benzoylarginine-2-Naphthylamide | 2 | 2007 | 4 | 0.040 |
Why?
|
| Proto-Oncogenes | 1 | 1997 | 321 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1280 | 0.040 |
Why?
|
| Biopolymers | 1 | 2017 | 188 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2001 | 734 | 0.040 |
Why?
|
| Dentifrices | 1 | 2016 | 6 | 0.040 |
Why?
|
| Polyethyleneimine | 1 | 2016 | 64 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 1364 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1875 | 0.030 |
Why?
|
| Protein Modification, Translational | 1 | 2015 | 21 | 0.030 |
Why?
|
| Antibodies, Neoplasm | 1 | 1997 | 286 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2021 | 1063 | 0.030 |
Why?
|
| Mutation | 3 | 2008 | 29981 | 0.030 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2015 | 48 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2020 | 1654 | 0.030 |
Why?
|
| Triclosan | 1 | 2016 | 56 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 4121 | 0.030 |
Why?
|
| Plasmids | 1 | 2001 | 2316 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 135 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20026 | 0.030 |
Why?
|
| Dental Calculus | 1 | 2015 | 12 | 0.030 |
Why?
|
| Bacteria, Anaerobic | 2 | 2008 | 68 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2017 | 340 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2020 | 511 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2001 | 954 | 0.030 |
Why?
|
| Replica Techniques | 1 | 2014 | 1 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1181 | 0.030 |
Why?
|
| Models, Biological | 2 | 2010 | 9569 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2017 | 612 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 1998 | 768 | 0.030 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2015 | 147 | 0.030 |
Why?
|
| Freeze Drying | 1 | 2014 | 98 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2005 | 2526 | 0.030 |
Why?
|
| Dental Instruments | 1 | 2014 | 17 | 0.030 |
Why?
|
| Ileocecal Valve | 1 | 2014 | 21 | 0.030 |
Why?
|
| Thermography | 1 | 2014 | 68 | 0.030 |
Why?
|
| Societies, Dental | 1 | 2014 | 33 | 0.030 |
Why?
|
| Plagiarism | 1 | 2014 | 22 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1898 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 1997 | 606 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 12868 | 0.030 |
Why?
|
| Freezing | 1 | 2014 | 305 | 0.030 |
Why?
|
| Bacteroides | 2 | 2007 | 161 | 0.030 |
Why?
|
| Tooth Migration | 1 | 2013 | 11 | 0.030 |
Why?
|
| Ice | 1 | 2014 | 104 | 0.030 |
Why?
|
| Epithelial Attachment | 1 | 2013 | 46 | 0.030 |
Why?
|
| Tooth Apex | 1 | 2013 | 31 | 0.030 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2015 | 351 | 0.030 |
Why?
|
| Crowns | 1 | 2014 | 153 | 0.030 |
Why?
|
| Keloid | 1 | 2013 | 50 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 22009 | 0.030 |
Why?
|
| Phenazines | 1 | 1993 | 58 | 0.030 |
Why?
|
| Washington | 1 | 2014 | 314 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1843 | 0.030 |
Why?
|
| Animal Feed | 1 | 2013 | 113 | 0.030 |
Why?
|
| Platelet-Rich Plasma | 1 | 2016 | 184 | 0.030 |
Why?
|
| Online Systems | 1 | 2014 | 184 | 0.030 |
Why?
|
| Mercury Poisoning | 1 | 1992 | 33 | 0.030 |
Why?
|
| Gelatin | 1 | 2014 | 232 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 1074 | 0.030 |
Why?
|
| Molar | 1 | 2013 | 153 | 0.030 |
Why?
|
| Color | 1 | 2013 | 304 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1998 | 1119 | 0.030 |
Why?
|
| Colon | 1 | 2020 | 1800 | 0.030 |
Why?
|
| Keratins | 1 | 2013 | 516 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 1353 | 0.030 |
Why?
|
| 24,25-Dihydroxyvitamin D 3 | 1 | 2011 | 8 | 0.030 |
Why?
|
| Cephalometry | 1 | 2013 | 383 | 0.020 |
Why?
|
| Gels | 2 | 2005 | 425 | 0.020 |
Why?
|
| Peer Review, Research | 1 | 2014 | 334 | 0.020 |
Why?
|
| Pigmentation | 1 | 2011 | 148 | 0.020 |
Why?
|
| Skin | 1 | 2004 | 4393 | 0.020 |
Why?
|
| Photography | 1 | 2013 | 523 | 0.020 |
Why?
|
| Bibliometrics | 1 | 2014 | 348 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2014 | 1906 | 0.020 |
Why?
|
| Bronchi | 1 | 2014 | 851 | 0.020 |
Why?
|
| Adolescent | 4 | 2011 | 86713 | 0.020 |
Why?
|
| Mercury | 1 | 1992 | 285 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2001 | 9863 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 1998 | 1919 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2011 | 423 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1997 | 1666 | 0.020 |
Why?
|
| Binding Sites | 1 | 2018 | 6118 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 5858 | 0.020 |
Why?
|
| South Africa | 1 | 2015 | 1740 | 0.020 |
Why?
|
| Osteoporosis | 1 | 1999 | 1582 | 0.020 |
Why?
|
| Television | 1 | 1992 | 406 | 0.020 |
Why?
|
| Stomach | 1 | 2014 | 697 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4562 | 0.020 |
Why?
|
| DNA Probes | 2 | 2000 | 555 | 0.020 |
Why?
|
| Ameloblasts | 1 | 2008 | 17 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1998 | 6458 | 0.020 |
Why?
|
| Root Resorption | 1 | 2008 | 42 | 0.020 |
Why?
|
| Meningioma | 1 | 1997 | 1218 | 0.020 |
Why?
|
| Cicatrix | 1 | 2013 | 774 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2008 | 171 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 1997 | 2474 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 6417 | 0.020 |
Why?
|
| Algorithms | 2 | 2021 | 13984 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 20914 | 0.020 |
Why?
|
| Europe | 1 | 2014 | 3359 | 0.020 |
Why?
|
| Microchip Analytical Procedures | 1 | 2007 | 28 | 0.020 |
Why?
|
| International Cooperation | 1 | 2014 | 1439 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2007 | 3674 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 1680 | 0.020 |
Why?
|
| Public Health | 1 | 2020 | 2634 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2014 | 13011 | 0.020 |
Why?
|
| Tooth, Unerupted | 1 | 2005 | 4 | 0.020 |
Why?
|
| Mandibular Condyle | 1 | 2006 | 115 | 0.020 |
Why?
|
| Dental Pulp | 1 | 2006 | 87 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2012 | 3127 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2008 | 602 | 0.020 |
Why?
|
| Computers, Handheld | 1 | 2007 | 208 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 2005 | 203 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7805 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 1537 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2006 | 217 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 5860 | 0.010 |
Why?
|
| Solubility | 1 | 2006 | 1091 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2001 | 15164 | 0.010 |
Why?
|
| Patient Preference | 1 | 2011 | 899 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2007 | 1798 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10914 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2008 | 1407 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2008 | 729 | 0.010 |
Why?
|
| Gingival Hyperplasia | 1 | 2002 | 19 | 0.010 |
Why?
|
| Membranes | 1 | 2002 | 172 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 1177 | 0.010 |
Why?
|
| beta Catenin | 1 | 2007 | 1066 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 1067 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 1459 | 0.010 |
Why?
|
| Capsules | 1 | 2001 | 196 | 0.010 |
Why?
|
| Tooth Calcification | 1 | 2000 | 8 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2001 | 917 | 0.010 |
Why?
|
| Reference Values | 1 | 2008 | 4994 | 0.010 |
Why?
|
| Treponema | 1 | 1999 | 38 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11091 | 0.010 |
Why?
|
| Campylobacter | 1 | 1999 | 59 | 0.010 |
Why?
|
| Actinomyces | 1 | 1999 | 39 | 0.010 |
Why?
|
| Fusobacterium | 1 | 1999 | 54 | 0.010 |
Why?
|
| Prevotella | 1 | 1999 | 79 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 1944 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 2006 | 1812 | 0.010 |
Why?
|
| Drug Approval | 1 | 2006 | 786 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3589 | 0.010 |
Why?
|
| Streptozocin | 1 | 1998 | 196 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2002 | 616 | 0.010 |
Why?
|
| Prognosis | 1 | 1998 | 29264 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2010 | 4248 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1997 | 218 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1997 | 322 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 203 | 0.010 |
Why?
|
| Schwann Cells | 1 | 1997 | 203 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 492 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2007 | 3021 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 13778 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1997 | 1102 | 0.010 |
Why?
|
| Prevalence | 1 | 1993 | 15404 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2001 | 2978 | 0.010 |
Why?
|
| Neutrophils | 1 | 2008 | 3729 | 0.010 |
Why?
|
| Lung | 1 | 2014 | 9990 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1997 | 1089 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1676 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 18050 | 0.010 |
Why?
|
| Cell Separation | 1 | 2000 | 1751 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 29630 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 5774 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 5965 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2007 | 5107 | 0.010 |
Why?
|
| Femur | 1 | 1998 | 1308 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 15657 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 2881 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1997 | 1978 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 3626 | 0.010 |
Why?
|
| Sex Factors | 1 | 2001 | 10469 | 0.000 |
Why?
|
| Age Factors | 1 | 2001 | 18460 | 0.000 |
Why?
|
| Child | 1 | 1993 | 78594 | 0.000 |
Why?
|
| Brain | 1 | 1997 | 26598 | 0.000 |
Why?
|